Shares of Applied Therapeutics, Inc. (APLT) are surging more than 40 percent Wednesday morning after the clinical-stage biopharmaceutical company announced a private placement to the tune of $100 million.
The company intends to use gross proceeds from the offering of 100 million to fund commercial activities for govorestat, to develop pipeline candidates, and for general corporate purposes.
Applied Therapeutics added that net proceeds, along with existing cash and cash equivalents, are expected to extend cash runway into 2026.
The company has entered into a definitive securities purchase agreement for the sale of 12,285,714 shares at $7.00 per share and 2,000,000 pre-funded warrants to purchase shares at $6.999 per share, in a private placement, which is expected to close by March 1.
APLT, currently at $7.90, touched a new high of $9.39 this morning.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.